Author:
Yilmaz H.,Cakmak M.,Inan O.,Darcin T.,Akcay A.
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Reference33 articles.
1. Ho JE, Liu C, Lyass A, Courchesne P, Pencina MJ, Vasan RS, Larson MG, Levy D (2012) Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community. J Am Coll Cardiol 60(14):1249–1256
2. de Boer RA, van Veldhuisen DJ, Gansevoort RT, Muller Kobold AC, van Gilst WH, Hillege HL, Bakker SJ, van der Harst P (2012) The fibrosis marker galectin-3 and outcome in the general population. J Intern Med 272(1):55–64
3. van der Velde AR, Gullestad L, Ueland T, Aukrust P, Guo Y, Adourian A, Muntendam P, van Veldhuisen DJ, de Boer RA (2013) Prognostic value of changes in galectin-3 levels over time in patients with heart failure: data from CORONA and COACH. Circ Heart Fail 6(2):219–226
4. Djoussé L, Matsumoto C, Petrone A, Weir NL, Tsai MY, Gaziano JM (2013) Plasma galectin 3 and heart failure risk in the Physicians’ Health Study. Eur J Heart Fail. doi: 10.1002/ejhf.21
5. Barrow H, Rhodes JM, Yu LG (2013) Simultaneous determination of serum galectin-3 and -4 levels detects metastases in colorectal cancer patients. Cell Oncol (Dordr) 36(1):9–13
Cited by
66 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献